Request Info
Request Info

Fennec News

FENNEC APPOINTS SHUBH GOEL AS CHIEF COMMERCIAL OFFICER

Seasoned commercial leader to lead the anticipated launch of PEDMARKTM Research Triangle Park, NC, September 9, 2019 – Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARKTM (a... Read More

FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING

Research Triangle Park, NC — (Marketwired) – June 18, 2019 – Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14, 2019 (the “Circular”)... Read More

Sign up for Updates